Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 153

Sort by

Sort Order Select

Journal Articles

Predictors of discordant end-of-treatment PET positivity in advanced-stage classical Hodgkin lymphoma patients with negative interim PET response

Alaa Hamad, Chams Alkhalaf Albachir, Saleha Abdul Rab, Riad Elfakih, Mahmoud Aljurf, Mohamed Isam Sharif, Walid Rasheed, Alfadel Alshaibani

Blood (2025) 146 (Supplement 1): 7139.

https://doi.org/10.1182/blood-2025-7139

Published: 2025

Journal Articles

Immune tolerance induction after haploidentical stem cell transplant following organ transplantation in sickle cell disease

Ali Alahmari, Saad Alghamdi, Reem Alasbali, Manar Aleid, Hadeel Samarkandi, Hassan Aleid, Syed Ahmed, Shaykhah Alotaibi, Dieter Broering, Mostafa Saleh, Waleed Al-hamoudi, Sara Samarkandi, Walid Rasheed, Adetola Kassim, Hazza Alzahrani, Mahmoud Aljurf, Fahad Almohareb

Blood (2025) 146 (Supplement 1): 4216.

https://doi.org/10.1182/blood-2025-4216

Published: 2025

Journal Articles

Impact of conditioning regimen on outcomes of adolescents and young adults AML patients undergoing HCT in complete remission, with transplant conditioning intensity score of 3.5-4.0. a study from the acute leukemia working party of the european society for blood and marrow transplantation.

Blood (2025) 146 (Supplement 1): 112.

https://doi.org/10.1182/blood-2025-112

Published: 2025

Journal Articles

Hematopoietic stem cell transplantation for relapsed classical Hodgkin lymphoma: A benchmark Study on 19,498 patients from the EBMT lymphoma working party

Blood (2025) 146 (Supplement 1): 4521.

https://doi.org/10.1182/blood-2025-4521

Published: 2025

Journal Articles

Comparable outcomes of haploidentical, sibling, and unrelated donor transplantation for adult T-ALL in second remission: a study from the global committee and ALWP of the EBMT

Blood (2025) 146 (Supplement 1): 2526.

https://doi.org/10.1182/blood-2025-2526

Published: 2025

Journal Articles

Low-dose post-transplant cyclophosphamide for GvHD prophylaxis in haploidentical stem cell transplantation: A systematic review of efficacy, toxicity, and survival outcomes

Areez Shafqat, Omar Ahmad, Mohammed Omer, Shameel Shafqat, Abdulrahman Nasiri, Ahmed Kotb, Ali Mushtaq, Mary Harnegie, Ali Al-Ahmari, Syed Ahmed, Walid Rasheed, Hazza Alzahrani, Mahmoud Aljurf, Riad Elfakih, Mostafa Saleh

Blood (2025) 146 (Supplement 1): 7775.

https://doi.org/10.1182/blood-2025-7775

Published: 2025

Journal Articles

Prognostic significance of PNH clones in aplastic anemia treated with immunosuppression or allogeneic HSCT

Blood (2025) 146 (Supplement 1): 4967.

https://doi.org/10.1182/blood-2025-4967

Published: 2025

Journal Articles

Xeroderma pigmentosum as a germline predisposition syndrome for haematological malignancies

Blood (2025) 146 (Supplement 1): 6749.

https://doi.org/10.1182/blood-2025-6749

Published: 2025

Journal Articles

Outcomes of 544 patients with t(6;9) Acute Myeloid Leukemia undergoing allogeneic stem cell transplantation: An EBMT Study on behalf of the acute leukemia working party (ALWP) and the pediatric diseases working party (PDWP)

Blood (2025) 146 (Supplement 1): 6066.

https://doi.org/10.1182/blood-2025-6066

Published: 2025

Journal Articles

Prognostic analysis of salvage allogeneic HCT in acute leukemia patients relapsing after autologous HCT: a study from the acute leukemia working party of the EBMT

Blood (2025) 146 (Supplement 1): 6041.

https://doi.org/10.1182/blood-2025-6041

Published: 2025

Journal Articles

IL-6 and ferritin levels predict the severity of cytopenia post CAR T-cell treatment with axi-cel for B cell lymphoma

Blood (2025) 146 (Supplement 1): 5495.

https://doi.org/10.1182/blood-2025-5495

Published: 2025

Journal Articles

Disrupting the global CAR T paradigm from the Middle East: Ultra-fast swift CAR T and scalable point-of-care manufacturing of autologous CAR T cells for hematologic malignancies

Farhatullah Syed, Walid Warda, Hanan Alqudairy, Nouf Alrasheed, Syed Ahmed, Abdullah Alsuliman, Moumenah Alkhaldi, Noura Hamideddin, Alaiya Abdulkareem, Alaa Doubi, Feras Alfraih, Ali Alahmari, Abdulwahab Albabtain, Amr Hanbali, Mahmoud Aljurf, Hazza Alzahrani, Ayman Saad, Riad Elfakih

Blood (2025) 146 (Supplement 1): 2406.

https://doi.org/10.1182/blood-2025-2406

Published: 2025

Journal Articles

Allogeneic hematopoietic cell transplantation in dyskeratosis congenita: Short and long- term outcome of 183 consecutive patients transplanted at EBMT centers

Blood (2025) 146 (Supplement 1): 2490.

https://doi.org/10.1182/blood-2025-2490

Published: 2025

Journal Articles

Thymoglobuline and grafalon show comparable transplant outcomes in patients with aplastic anemia undergoing allogeneic stem cell transplantation: A multicenter EBMT saawp study of 1603 patients

Blood (2025) 146 (Supplement 1): 3192.

https://doi.org/10.1182/blood-2025-3192

Published: 2025

Journal Articles

Clinical-genomic profiling of MDS to inform allo-HCT: recommendations from an international panel on behalf of the EBMT

Blood (2025) 145 (18): 1987–2001.

https://doi.org/10.1182/blood.2024025131

Published: 2025

Includes: Supplemental data

Journal Articles

Validation of the EBMT Multiple Myeloma Early Relapse Score within Worldwide Network for Blood and Marrow Transplantation (WBMT) Global Study

Blood (2024) 144 (Supplement 1): 4733.

https://doi.org/10.1182/blood-2024-200071

Published: 2024

Journal Articles

Saudi Acute Myeloid Leukaemia (AML) Genome Reveals Significant Differences from That in the Western Population

Blood (2024) 144 (Supplement 1): 4231.

https://doi.org/10.1182/blood-2024-205025

Published: 2024

Journal Articles

Maintenance after Autologous Hematopoietic Cell Transplantation Improves Overall Survival and Progression Free Survival Regardless of Disease Stage at Transplant in Newly Diagnosed Myeloma Patients: A Global, Real-World Analysis from the Worldwide Network for Blood and Marrow Transplantation Global Study

Andrew J. Cowan, Luuk Gras, Hiroyuki Takamatsu, Linda Koster, Laurien Baaij, III, Nada Hamad, Anita D'Souza, Noel Estrada-Merly, Parameswaran N. Hari, Wael Saber, Minako Iida, Shinichiro Okamoto, Shohei Mizuno, Koji Kawamura, Yoshihisa Kodera, Bor-Sheng Ko, Christopher Liam, KIM Wah HO, A Sim Goh, S Keat Tan, Alaa M. Elhaddad, Ali Bazarbachi, Brig Qamar Un N Chaudhry, Rozan Alfar, Mohamed Amine Bekadja, Malek Benakli, Cristobal Augusto Frutos Ortiz, Eloisa Riva, Sebastian Galeano, Francisca Bass, Hira Mian, Arleigh McCurdy, Feng-Rong Wang, Meng Lv, Daniel Neumann, Mickey Boon Chai Koh, John Snowden, Stefan Schonland, Donal P McLornan, Patrick John Hayden, Rafael De La Camara, Raffaella Greco, Fabio Ciceri, Mette D. Hazenberg, Anna Sureda Balari, Damiano Rondelli, Hildegard T. Greinix, Mahmoud Aljurf, Yoshiko Atsuta, Dietger W. Niederwieser, Laurent Garderet

Blood (2024) 144 (Supplement 1): 2379.

https://doi.org/10.1182/blood-2024-205709

Published: 2024

Journal Articles

In AML Patients Allografted in First Remission, DNMT3A Mutations Differentially Affect Post-Transplant Outcomes According to Karyotype, NPM1 and FLT3-ITD Mutation Status - from the EBMT-ALWP

Blood (2024) 144 (Supplement 1): 4315.

https://doi.org/10.1182/blood-2024-202764

Published: 2024

Journal Articles

Evaluating the Safety and Efficacy of Tyrosine Kinase Inhibitors in Pregnant Patients with Chronic Myeloid Leukemia: A Comprehensive 15-Year Single-Center Study

Blood (2024) 144 (Supplement 1): 4536.

https://doi.org/10.1182/blood-2024-207937

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Predictors of discordant end-of-treatment PET positivity in advanced-stage classical Hodgkin lymphoma patients with negative interim PET response

Immune tolerance induction after haploidentical stem cell transplant following organ transplantation in sickle cell disease

Impact of conditioning regimen on outcomes of adolescents and young adults AML patients undergoing HCT in complete remission, with transplant conditioning intensity score of 3.5-4.0. a study from the acute leukemia working party of the european society for blood and marrow transplantation.

Hematopoietic stem cell transplantation for relapsed classical Hodgkin lymphoma: A benchmark Study on 19,498 patients from the EBMT lymphoma working party

Comparable outcomes of haploidentical, sibling, and unrelated donor transplantation for adult T-ALL in second remission: a study from the global committee and ALWP of the EBMT

Low-dose post-transplant cyclophosphamide for GvHD prophylaxis in haploidentical stem cell transplantation: A systematic review of efficacy, toxicity, and survival outcomes

Prognostic significance of PNH clones in aplastic anemia treated with immunosuppression or allogeneic HSCT

Xeroderma pigmentosum as a germline predisposition syndrome for haematological malignancies

Outcomes of 544 patients with t(6;9) Acute Myeloid Leukemia undergoing allogeneic stem cell transplantation: An EBMT Study on behalf of the acute leukemia working party (ALWP) and the pediatric diseases working party (PDWP)

Prognostic analysis of salvage allogeneic HCT in acute leukemia patients relapsing after autologous HCT: a study from the acute leukemia working party of the EBMT

IL-6 and ferritin levels predict the severity of cytopenia post CAR T-cell treatment with axi-cel for B cell lymphoma

Disrupting the global CAR T paradigm from the Middle East: Ultra-fast swift CAR T and scalable point-of-care manufacturing of autologous CAR T cells for hematologic malignancies

Allogeneic hematopoietic cell transplantation in dyskeratosis congenita: Short and long- term outcome of 183 consecutive patients transplanted at EBMT centers

Thymoglobuline and grafalon show comparable transplant outcomes in patients with aplastic anemia undergoing allogeneic stem cell transplantation: A multicenter EBMT saawp study of 1603 patients

Clinical-genomic profiling of MDS to inform allo-HCT: recommendations from an international panel on behalf of the EBMT

Validation of the EBMT Multiple Myeloma Early Relapse Score within Worldwide Network for Blood and Marrow Transplantation (WBMT) Global Study

Saudi Acute Myeloid Leukaemia (AML) Genome Reveals Significant Differences from That in the Western Population

In AML Patients Allografted in First Remission, DNMT3A Mutations Differentially Affect Post-Transplant Outcomes According to Karyotype, NPM1 and FLT3-ITD Mutation Status - from the EBMT-ALWP

Evaluating the Safety and Efficacy of Tyrosine Kinase Inhibitors in Pregnant Patients with Chronic Myeloid Leukemia: A Comprehensive 15-Year Single-Center Study

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only